GlassScriptPhysician profile
Zula M Price
NPI 1922628130
$1,008.13
in general payments reported to CMS, 2019-2025
8 companies · $553 in 2025
The $553 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $332 · 2024: $123 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $250.00 | 2023 | Nuplazid |
| Novo Nordisk INC | $125.01 | 2025 | Wegovy |
| Averitas Pharma INC. | $122.68 | 2024 | Qutenza |
| Alexion Pharmaceuticals, INC. | $121.84 | 2025 | |
| Madrigal Pharmaceuticals | $111.34 | 2025 | Rezdiffra |
| Ars Pharmaceuticals Operations, INC. | $99.59 | 2025 | Neffy |
| Corcept Therapeutics | $95.54 | 2025 | Korlym |
| Axonics, INC. | $82.13 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zula Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.